304 related articles for article (PubMed ID: 19734938)
1. The neuroblastoma tumour-suppressor TrkAI and its oncogenic alternative TrkAIII splice variant exhibit geldanamycin-sensitive interactions with Hsp90 in human neuroblastoma cells.
Farina AR; Tacconelli A; Cappabianca L; Cea G; Chioda A; Romanelli A; Pensato S; Pedone C; Gulino A; Mackay AR
Oncogene; 2009 Nov; 28(46):4075-94. PubMed ID: 19734938
[TBL] [Abstract][Full Text] [Related]
2. Geldanamycin inhibits tyrosine phosphorylation-dependent NF-kappaB activation.
Crèvecoeur J; Merville MP; Piette J; Gloire G
Biochem Pharmacol; 2008 Jun; 75(11):2183-91. PubMed ID: 18455150
[TBL] [Abstract][Full Text] [Related]
3. Alternative TrkAIII splicing: a potential regulated tumor-promoting switch and therapeutic target in neuroblastoma.
Tacconelli A; Farina AR; Cappabianca L; Gulino A; Mackay AR
Future Oncol; 2005 Oct; 1(5):689-98. PubMed ID: 16556046
[TBL] [Abstract][Full Text] [Related]
4. Retrograde TrkAIII transport from ERGIC to ER: a re-localisation mechanism for oncogenic activity.
Farina AR; Cappabianca L; Ruggeri P; Gneo L; Maccarone R; Mackay AR
Oncotarget; 2015 Nov; 6(34):35636-51. PubMed ID: 26415233
[TBL] [Abstract][Full Text] [Related]
5. The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII.
Farina AR; Cappabianca L; Ruggeri P; Gneo L; Pellegrini C; Fargnoli MC; Mackay AR
J Exp Clin Cancer Res; 2018 Jun; 37(1):119. PubMed ID: 29914559
[TBL] [Abstract][Full Text] [Related]
6. TrkAIII expression in the thymus.
Tacconelli A; Farina AR; Cappabianca L; Cea G; Panella S; Chioda A; Gallo R; Cinque B; Sferra R; Vetuschi A; Campese AF; Screpanti I; Gulino A; Mackay AR
J Neuroimmunol; 2007 Feb; 183(1-2):151-61. PubMed ID: 17241672
[TBL] [Abstract][Full Text] [Related]
7. Geldanamycin interferes with the 90-kDa heat shock protein, affecting lipopolysaccharide-mediated interleukin-1 expression and apoptosis within macrophages.
Hsu HY; Wu HL; Tan SK; Li VP; Wang WT; Hsu J; Cheng CH
Mol Pharmacol; 2007 Jan; 71(1):344-56. PubMed ID: 16868182
[TBL] [Abstract][Full Text] [Related]
8. TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma.
Tacconelli A; Farina AR; Cappabianca L; Desantis G; Tessitore A; Vetuschi A; Sferra R; Rucci N; Argenti B; Screpanti I; Gulino A; Mackay AR
Cancer Cell; 2004 Oct; 6(4):347-60. PubMed ID: 15488758
[TBL] [Abstract][Full Text] [Related]
9. The heat-shock protein 90 inhibitor, geldanamycin, induces apoptotic cell death in Epstein-Barr virus-positive NK/T-cell lymphoma by Akt down-regulation.
Jeon YK; Park CH; Kim KY; Li YC; Kim J; Kim YA; Paik JH; Park BK; Kim CW; Kim YN
J Pathol; 2007 Oct; 213(2):170-9. PubMed ID: 17768706
[TBL] [Abstract][Full Text] [Related]
10. Resistance to geldanamycin-induced apoptosis in differentiated neuroblastoma SH-SY5Y cells.
Shen JH; Zhang Y; Wu NH; Shen YF
Neurosci Lett; 2007 Mar; 414(2):110-4. PubMed ID: 17293044
[TBL] [Abstract][Full Text] [Related]
11. Proteome-wide changes induced by the Hsp90 inhibitor, geldanamycin in anaplastic large cell lymphoma cells.
Schumacher JA; Crockett DK; Elenitoba-Johnson KS; Lim MS
Proteomics; 2007 Aug; 7(15):2603-16. PubMed ID: 17610208
[TBL] [Abstract][Full Text] [Related]
12. Effects of Hsp90 inhibition in neuroblastoma: analysis of drug sensitivity, target modulation and the influence of bone marrow microenvironment.
Jayanthan A; Fowler J; Hawkins L; Lamers F; Teja B; Incoronato A; Anderson R; Narendran A
J Exp Ther Oncol; 2008; 7(3):183-93. PubMed ID: 19066127
[TBL] [Abstract][Full Text] [Related]
13. TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TrkAIII in SH-SY5Y cells, unveiling a potential therapeutic "Achilles heel" for the TrkAIII oncoprotein in neuroblastoma.
Gneo L; Ruggeri P; Cappabianca L; Farina AR; Di Ianni N; Mackay AR
Oncotarget; 2016 Dec; 7(49):80820-80841. PubMed ID: 27821809
[TBL] [Abstract][Full Text] [Related]
14. Molecular Characterization and Inhibition of a Novel Stress-Induced Mitochondrial Protecting Role for Misfolded TrkAIII in Human SH-SY5Y Neuroblastoma Cells.
Cappabianca L; Ruggieri M; Sebastiano M; Sbaffone M; Martelli I; Ruggeri P; Di Padova M; Farina AR; Mackay AR
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791513
[TBL] [Abstract][Full Text] [Related]
15. The TrkAIII oncoprotein inhibits mitochondrial free radical ROS-induced death of SH-SY5Y neuroblastoma cells by augmenting SOD2 expression and activity at the mitochondria, within the context of a tumour stem cell-like phenotype.
Ruggeri P; Farina AR; Di Ianni N; Cappabianca L; Ragone M; Ianni G; Gulino A; Mackay AR
PLoS One; 2014; 9(4):e94568. PubMed ID: 24736663
[TBL] [Abstract][Full Text] [Related]
16. The alternative TrkAIII splice variant targets the centrosome and promotes genetic instability.
Farina AR; Tacconelli A; Cappabianca L; Cea G; Panella S; Chioda A; Romanelli A; Pedone C; Gulino A; Mackay AR
Mol Cell Biol; 2009 Sep; 29(17):4812-30. PubMed ID: 19564412
[TBL] [Abstract][Full Text] [Related]
17. Geldanamycin, a heat shock protein 90-binding agent, disrupts Stat5 activation in IL-2-stimulated cells.
Xu W; Yu F; Yan M; Lu L; Zou W; Sun L; Zheng Z; Liu X
J Cell Physiol; 2004 Feb; 198(2):188-96. PubMed ID: 14603521
[TBL] [Abstract][Full Text] [Related]
18. The Ah receptor is a sensitive target of geldanamycin-induced protein turnover.
Chen HS; Singh SS; Perdew GH
Arch Biochem Biophys; 1997 Dec; 348(1):190-8. PubMed ID: 9390191
[TBL] [Abstract][Full Text] [Related]
19. HSP90 antagonist, geldanamycin, inhibits proliferation, induces apoptosis and blocks migration of rhabdomyosarcoma cells in vitro and seeding into bone marrow in vivo.
Lesko E; Gozdzik J; Kijowski J; Jenner B; Wiecha O; Majka M
Anticancer Drugs; 2007 Nov; 18(10):1173-81. PubMed ID: 17893518
[TBL] [Abstract][Full Text] [Related]
20. Theileria-induced constitutive IKK activation is independent of functional Hsp90.
Hermann P; Dobbelaere DA
FEBS Lett; 2006 Sep; 580(21):5023-8. PubMed ID: 16938294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]